Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
54%
OVERLAP
BY WEIGHT
38
# OF OVERLAPPING
HOLDINGS
WELS.DE
86
HOLDINGS
45%
ALSO IN XDG3.DE
XDG3.DE
111
HOLDINGS
36%
ALSO IN WELS.DE
SECTOR DRIFT (WELS.DE minus XDG3.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WELS.DE |
Weight in XDG3.DE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 5.0% | 5.0% |
|
MERCK & CO. INC. | 4.8% | 4.8% | 4.8% |
|
ABBVIE INC | 6.9% | 4.6% | 4.6% |
 |
ASTRAZENECA PLC | 4.6% | 4.5% | 4.5% |
|
AMGEN INC | 3.1% | 4.6% | 3.1% |
WELS.DE Overweight Relative to XDG3.DE
|
ELI LILLY & CO | 7.0% |
|
UNITEDHEALTH GROUP INC | 6.2% |
 |
NOVARTIS AG | 4.1% |
|
INTUITIVE SURGICAL INC | 2.6% |
|
ABBVIE INC | 2.3% |
|
CVS CAREMARK CORP | 1.5% |
|
ELEVANCE HEALTH INC | 1.4% |
|
CIGNA CORPORATION | 1.1% |
|
CENCORA INC | 0.9% |
|
HCA HOLDINGS INC | 0.9% |
WELS.DE Underweight Relative to XDG3.DE
|
VERTEX PHARMACEUTICALS INC | -3.1% |
 |
NOVO NORDISK A/S-B | -2.6% |
|
STRYKER CORP | -2.5% |
|
BRISTOL-MYERS SQUIBB CO | -2.4% |
|
DANAHER CORP | -2.0% |
|
GILEAD SCIENCES INC | -1.6% |
 |
SANOFI-AVENTIS | -1.6% |
|
AMGEN INC | -1.5% |
|
REGENERON PHARMACEUTICALS | -1.5% |
|
GSK PLC | -1.4% |